期刊文献+

氨苯砜综合征诊治探讨——附6例报告 被引量:1

Diagnosis and treatment of dapsone syndrome——a report of six cases.
下载PDF
导出
摘要 目的:探讨氨苯砜综合征的诊治要点:方法:对6例氨苯砜综合征患者的临床资料进行回顾性分析。结果和结论:6例氨苯砜综合征患者均为中青年,从服药到出现症状的时间较长,为9~55日.6例患者均以高热起病,起病急骤、凶险,病初均有麻疹紫癜样皮疹,皮疹多形,严重者出现尼氏征阳性或阴性的大疱和(或)全身性红皮病样皮疹;均有浅表淋巴结肿大;多数患者有血液系统损害;并均有肝损害:确诊后及时停氨苯砜,给予足量肾上腺皮质激素和(或)大剂量免疫球蛋白静脉注射,以及支持对症处理,住院12~80(中位数53)日,4例痊愈,1例病情得到控制,另1例因治疗第2日自动出院放弃治疗,死于肝功能衰竭?提示氨苯砜综合征需要及时、正确处理,否则预后不良. Objective: To discuss the key points for the diagnosis and treatment of dapsone syndrome. Methods: Six cases with dapsone syndrome were retrospectively analyzed. Results and Conclusion: Six cases with dapsone syndrome were all middle-aged and young. Dapsone syndrome had long latent period (9 -55 days). The onset of dapsone syndrome was acute and severe, manifested with hyperpyrexia. Various rashes were found, appeared as measlesurpura, bullae with or without positive Nikolsky's sign and/or erythrodermia. All had superficial lymph nodes enlargement. Most dapsone syndrome had involvement of hematological system. All had liver involvement. The condition would be controlled bv immediate discontinuation of the dapsone combining the use of corticosteroid and/or high-dose intravenous immunoglobulin after definite diagnosis. Supporting and symptomatic treatments were needed. The length of hospitalization was 53 ( 12 -80) days. Four cases recovered completely and were discharged. One case was controlled. One case died of liver function failure after leaving hospital automatically in the second day of treatment. The study suggests that dapsone syndrome should be treated promptly and correctly. Otherwise it would have poor prognosis.
出处 《新医学》 北大核心 2006年第10期641-643,共3页 Journal of New Medicine
关键词 氨苯砜 综合征 肾上腺皮质激素 红皮病 麻风病 Dapsone Syndrome Adrenal cortex hormone Ervthrodermia Leprosy
  • 相关文献

参考文献5

二级参考文献5

  • 1冯素英,靳培英.静脉滴注免疫球蛋白治疗皮肤病的现状[J].中华皮肤科杂志,2005,38(6):396-398. 被引量:24
  • 2Ibanez C,Montoro-Ronsano JB.Intravenous immunoglobulin preparations and autoimmune disorders:mechanisms of action.Curr Pharm Biotechnol,2003,4:239-247.
  • 3Mydlarski PR,Mittmann N,Shear NH.Intravenous immunoglobulin:use in dermatology.Skin Therapy Lett,2004,9:1-6.
  • 4Ahmed AR,Dahl MV.Consensus statement on the use of intravenous immunoglobulin therapy in the treatment of autoimmune mucocutaneous blistering diseases.Arch Dermatol,2003,139:1051-1059.
  • 5顾有守.皮肤药物不良反应的临床新发现[J].临床皮肤科杂志,2003,32(5):298-299. 被引量:43

共引文献22

同被引文献1

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部